Home Regeneron Pharmaceuticals Rating Reiterated by Piper Jaffray
 

Keywords :   


Regeneron Pharmaceuticals Rating Reiterated by Piper Jaffray

2015-10-04 23:23:38| Biotech - Topix.net

's stock had its "hold" rating restated by stock analysts at Piper Jaffray in a research report issued to clients and investors on Sunday, Analyst Ratings.Net reports. Shares of Regeneron Pharmaceuticals traded up 1.29% during trading on Friday, reaching $479.07.

Tags: rating pharmaceuticals piper jaffray

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.05The farmers counting the cost of a wet winter
29.05Samsung Electronics union calls first-ever strike
29.05Feedlot inventories below last year
29.05Ex-FTX executive sentenced to over 7 years in prison
29.05Insulation scandal: I have to scrape mould off the walls every two weeks'
29.05Eastern North Pacific Tropical Weather Outlook
29.05Atlantic Tropical Weather Outlook
29.05PM pledges to swap 'rip-off' degrees for apprenticeships
More »